Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.75M | -2.42M | -2.53M | -2.24M | -1.55M |
| Total Depreciation and Amortization | 800.00 | 800.00 | 800.00 | 900.00 | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 655.20K | 318.00K | 574.50K | 645.00K | 525.10K |
| Change in Net Operating Assets | 1.36M | 836.40K | 93.30K | 23.20K | 125.30K |
| Cash from Operations | -736.10K | -1.26M | -1.86M | -1.57M | -901.40K |
| Capital Expenditure | -197.30K | -183.60K | -194.00K | -153.80K | -110.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -197.30K | -183.60K | -194.00K | -153.80K | -110.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.64M | 1.73M | 3.35M | 3.33M | 1.71M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -295.60K | -297.60K | -363.70K | 30.20K | 98.90K |
| Cash from Financing | 986.10K | 1.05M | 2.13M | 2.40M | 1.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 52.70K | -398.20K | 72.90K | 675.30K | 256.20K |